Cost-effectiveness of In Vitro Fertilization

ABSTRACT

In vitro fertilization (IVF) is an effective but underutilized treatment for long-standing infertility. The median projected cost per IVF cycle in 2001 in the United States would be $9226 and $3531 in 25 other countries, based on previously published estimates. The cost per delivery arising from IVF cycles in 2001 in the United States would average $56,419, and $20,522 in eight other countries, based on previously published estimates. The cost-effectiveness of IVF has not been proven in three randomized controlled trials, but these trials are difficult to design and implement. Multiple gestation births significantly increase the cost of IVF treatment. IVF multiple births cost 36% more than the IVF cycles that gave rise to the multiple births. The uptake of IVF in most countries falls short of the minimum 1500 cycles per annum that would be needed per million population. Comparative international data indicate that infertile couples would increase their uptake of IVF services if the price were lower.

KEYWORD

In vitro fertilization - cost-effectiveness - economic analysis - utilization

REFERENCES

• 1 U.S. Congress Office of Technology Assessment. Infertility: Medical and Social Choices Washington, DC: U.S. Government Printing Office; 1988
• 2 Neumann P J, Weinstein M C, Gharib S D. The cost of a successful delivery with in vitro fertilization.  N Engl J Med . 1994;  331 239-243
• 3 Chandra A, Stephen E H. Impaired fecundity in the United States: 1982-1995.  Fam Plann Perspect . 1998;  30 34-42
• 4 Society for Assisted Reproductive Technology/American Society for Reproductive Medicine. Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry.  Fertil Steril . 2000;  74 641-653
• 5 Stovall D W, Allen B D, Sparks A ET, Syrop C H, Saunders R G, van Voorhis J B. The cost of infertility evaluation and therapy: findings of a self-insured university healthcare plan.  Fertil Steril . 1999;  72 778-784
• 6 Giacomini M, Hurley J, Stoddart G. The many meanings of deinsuring a health service: the case of in vitro fertilization in Ontario.  Soc Sci Med . 2000;  50 1485-500
• 7 Byford S, Raftery J. Perspectives in economic evaluation.  BMJ . 1998;  316 1529-1530
• 8 Goldfarb J M, Austin C, Lisbona H, Peskin B, Clapp M. Cost-effectiveness of in vitro fertilization.  Obstet Gynecol . 1996;  87 18-21
• 9 van Voorhis J B, Syrop C H, Allen B D, Sparks A ET, Stovall D W. The efficacy and cost effectiveness of embryo cryopreservation compared with other assisted reproductive techniques.  Fertil Steril . 1995;  64 647-650
• 10 Trad F S, Hornstein M D, Barbieri R L. In vitro fertilization: a cost-effective alternative for infertile couples?.  J Assist Reprod Genet . 1995;  12 418-421
• 11 Collins J A, Bustillo M, Visscher R D, Lawrence L D. An estimate of the cost of in vitro fertilization services in the United States in 1995.  Fertil Steril . 1995;  64 538-545
• 12 U.S. Bureau of the Census. Statistical Abstract of the United States: 1997; 117, Table No. 169. Consumer Price Indexes of Medical Care Prices: 1980 to 1996. Human Fertilisation and Embryology Authority; 1997
• 13 Blumenthal D. Controlling health care expenditures.  N Engl J Med . 2001;  344 766-769
• 14 Fluker M R, Tiffin G J. Assisted reproductive technologies: a primer for Canadian physicians.  J Soc Obstet Gynecol Can . 1996;  18 451-465
• 15 Goverde A J, McDonnell J, Vermeiden J PW, Schats R, Rutten F FH, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility.  Lancet . 2000;  355 13-18
• 16 Granberg M, Wikland M, Hamberger L. Financing of IVF/ET in the Nordic countries.  Acta Obstet Gynecol Scand . 1998;  77 63-67
• 17 Haan G, van Steen R. Costs in relation to effects of in-vitro fertilization.  Hum Reprod . 1992;  7 982-986
• 18 Holst N, Maltau J M, Forsdahl F, Hansen L J. Handling of tubal infertility after introduction of in vitro fertilization: changes and consequences.  Fertil Steril . 1991;  55 140-143
• 19 Mantovani L G, Belisari A, Szymanski L M. Pharmaco-economic aspects of in-vitro fertilization in Italy.  Hum Reprod . 1999;  14 953-958
• 20 Philips Z, Barraza-Llorens M, Posnett J. Evaluation of the relative cost-effectiveness of treatments for infertility in the UK.  Hum Reprod . 2000;  15 95-106
• 21 Schenker J, Shushan A. Ethical and legal aspects of assisted reproduction practice in Asia.  Hum Reprod . 1996;  11 908-911
• 22 Pavlovich C P, Schlegel P N. Fertility options after vasectomy: a cost-effectiveness analysis.  Fertil Steril . 1997;  67 133-141
• 23 Karande V C, Korn A, Morris R. Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility.  Fertil Steril . 1999;  71 468-475
• 24 Palmer S, Byford S, Raftery J. Types of economic evaluation.  BMJ . 1999;  318 1349
• 25 Gafni A. Willingness-to-pay as a measure of benefits.  Med Care . 1991;  29 1246-1252
• 26 Granberg M, Wikland M, Nilsson L, Hamberger L. Couples' willingness to pay for IVF-ET.  Acta Obstet Gynecol Scand . 1995;  74 199-202
• 27 Neumann P J, Johannesson M. The willingness to pay for in vitro fertilization: a pilot study using contingent evaluation.  Med Care . 1994;  32 686-699
• 28 Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation.  Soc Sci Med . 1999;  48 535-546
• 29 Ganiats T G, Browner D K, Kaplan R M. Comparison of two methods of calculating quality-adjusted life years.  Qual Life Res . 1996;  5 162-164
• 30 Torgerson D, Raftery J. Economic notes: measuring outcomes in economic evaluations.  BMJ . 1999;  318 1413
• 31 O'Brien B J, Heyland D, Richardson W S, Levine M, Drummond M F. Users' guides to the medical literature XIII: how to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients?.  <~>Evidence-Based Medicine Working Group. JAMA . 2001;  277 1802-1806
• 32 Soliman S, Daya S, Collins J, Jarrell J F. A randomized trial of in vitro fertilization versus conventional treatment for infertility.  Fertil Steril . 1993;  59 1239-1244
• 33 Goeree R, Labelle R, Jarrell J F. Cost-effectiveness of an in-vitro fertilization program and the costs of associated hospitalizations and other infertility treatments. In: Royal Commission on New Reproductive Technologies, ed. Proceed with Care: Final Report of the Royal Commission on New Reproductive Technologies Ottawa: Ministry of Supply and Services 1993: 569-599
• 34 Meldrum D R, Silverberg K M, Bustillo M, Stokes L. Success rate with repeated cycles of in vitro fertilization-embryo transfer.  Fertil Steril . 1998;  69 1005-1009
• 35 The ESHRE Capri Workshop Group. Guidelines to the prevalence, diagnosis, treatment and management of infertility, 1996.  Hum Reprod . 1996;  11 1775-1807
• 36 Collins J A, Feeny D, Gunby J. The cost of infertility diagnosis and treatment in Canada in 1995.  Hum Reprod . 1997;  12 951-958
• 37 Mol B WJ, Bonsel G J, Collins J A, Wiegerinck M H M A, van der Veen F, Bossuyt P MM. Cost-effectiveness of in vitro fertilization and embryo transfer.  Fertil Steril . 2000;  73 748-754
• 38 Callahan T L, Hall J E, Ettner S L, Christiansen C L, Greene M F, Crowley W F. The economic impact of multiple gestation pregnancies and the contribution of assisted reproduction.  N Engl J Med . 1994;  331 244-249
• 39 Jarrell J F, Labelle R, Goeree R, Milner R, Collins J. A randomized controlled trial of in vitro fertilization and embryo transfer.  Online J Curr Clin Trials . 1993;  Jul 2 DocNo.73
• 40 Health Council of the Netherlands: Committee on in vitro fertilization (IVF). In Vitro Fertilization Rijswijk: Health Council of the Netherlands; 1997
• 41 Lynch A, McDuffie R, Murphy J, Faber K, Leff M, Orleans M. Assisted reproductive interventions and multiple birth.  Obstet Gynecol . 2001;  97 195-200
• 42 Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion. Contribution of assisted reproductive technology and ovulation-inducing drugs to triplet and higher-order multiple births: United States 1980-1997.  MMWR . 2000;  49 535-538
• 43 Papiernik E. Social cost of twin births.  Acta Genet Med Gemellol . 1983;  32 105-111
• 44 Papiernik E. Costs of multiple pregnancies. In: Harvey D, Bryan E, eds. The Stress of Multiple Births London: Multiple Births Foundation 1991: 22-34
• 45 Collins J A, Graves G R. The economic consequences of multiple gestation pregnancy in assisted conception cycles.  Human Fertility . 2000;  3 275-283
• 46 The ESHRE Capri Workshop Group. Social determinants of human reproduction.  Hum Reprod . 2001;  16 1518-1526
• 47 Sundby J, Mboge R, Sonko S. Infertility in the Gambia: frequency and health care seeking.  Soc Sci Med . 1998;  46 891-899
• 48 Zarger A H, Wani A I, Masoodi S R, Laway B A, Salahuddin M. Epidemiologic and etiologic aspects of primary infertility in the Kashmir region of India.  Fertil Steril . 1997;  68 637-643
• 49 Templeton A, Fraser C, Thompson B. The epidemiology of infertility in Aberdeen.  BMJ . 1990;  301 148-152
• 50 Schmidt L, Munster K. Infertility, involuntary infecundity, and seeking of medical assistance in industrialized countries: a review of concepts, measurements and results.  Hum Reprod . 1995;  10 1407-1418
• 51 Olsen J, Kuppers-Chinnow M, Spinelli A. Seeking medical help for subfecundity: a study based upon surveys in five European countries.  Fertil Steril . 1996;  66 95-100
• 52 de Mouzon J, Lancaster P. World collaborative report on in vitro fertilization preliminary data for 1995.  J Assist Reprod Genet . 1997;  14 251S-265S
• 53 EIM Programme. Registers on IVF treatment in Europe 1999.  Focus on Reproduction . 1999;  3 9
• 54 World Health Organization. World Health Statistics Annual Geneva: WHO 1995: B-625
• 55 Daya S, Gunby J, Hughes E G, Collins J A, Sagle M A, YoungLai E V. Natural cycles for in-vitro fertilization: cost-effectiveness analysis and factors influencing outcome.  Hum Reprod . 1995;  10 1719-1724
• 56 Nargund G, Waterstone J, Bland J M, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles.  Hum Reprod . 2001;  16 259-262
• 57 Janssens R M, Lambalk C B, Vermeiden J P, Schats R, Schoemaker J. In-vitro fertilization in a spontaneous cycle: easy, cheap and realistic.  Hum Reprod . 2000;  15 314-318
• 58 Vilska S, Tiitinen A, Hyden-Granskog C, Hovatta O. Elective transfer of one embryo results in an acceptable pregnancy rate and eliminates the risk of multiple birth.  Hum Reprod . 1999;  14 2392-2395